BioGenerator wants to build more St. Louis companies—and that means a storytelling blitz
One evening in November, a class of about 30 WashU graduate students trickled onto the Cortex campus to learn more about BioGenerator Ventures, the investment arm of the bio-sciences ecosystem nonprofit BioSTL. They were met there by James McCarter, the new head of BioGenerator. McCarter, a major player in St. Louis’ bioscience industry, assumed his role in October. He sees untapped potential for investment particularly at WashU Medicine, which both this year and last garnered the second-highest amount of research funding among all U.S. medical schools from the National Institutes of Health.